Lichen Simplex Chronicus clinical trials

Explore recruiting lichen simplex chronicus clinical trials.

Recruiting lichen simplex chronicus studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lichen Simplex Chronicus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

Greece, Germany, Spain, Italy, Hungary, Belgium +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of dupilumab for the treatment of pruritus of Lichen Simplex Chronicus (LSC) in adults

Hungary, Italy, Germany, Belgium, Greece, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lichen Simplex Chronicus trials by city

Lichen Simplex Chronicus in Toronto Lichen Simplex Chronicus in Vancouver Lichen Simplex Chronicus in Montreal Lichen Simplex Chronicus in Calgary Lichen Simplex Chronicus in Edmonton Lichen Simplex Chronicus in Ottawa Lichen Simplex Chronicus in Winnipeg Lichen Simplex Chronicus in Quebec City Lichen Simplex Chronicus in Hamilton Lichen Simplex Chronicus in Kitchener Lichen Simplex Chronicus in London Lichen Simplex Chronicus in Halifax Lichen Simplex Chronicus in New York Lichen Simplex Chronicus in Los Angeles Lichen Simplex Chronicus in Chicago Lichen Simplex Chronicus in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease